ImVitro develops EMBRYOLY, an AI-driven software that integrates with time-lapse microscopes to enhance embryo evaluation by analyzing imaging data alongside patient-specific clinical characteristics. This technology increases pregnancy rates in IVF cycles while reducing administrative workload and operational costs for fertility clinics.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In vitro fertilization (IVF) clinics face challenges in accurately and efficiently evaluating embryo quality, a critical factor in determining pregnancy success rates. Traditional embryo assessment relies on manual observation and subjective scoring, which can be time-consuming, labor-intensive, and prone to variability. This can lead to suboptimal embryo selection, potentially reducing the chances of successful implantation and live birth.
Solution
ImVitro's EMBRYOLY is an AI-powered software designed to enhance embryo evaluation by integrating with time-lapse microscopy systems. The software analyzes imaging data in conjunction with patient-specific clinical characteristics to provide a more comprehensive and objective assessment of embryo viability. By automating and standardizing the evaluation process, EMBRYOLY aims to improve pregnancy rates in IVF cycles while simultaneously reducing the administrative burden and operational costs for fertility clinics. The platform supports integration with various time-lapse microscope models and offers features for managing cryopreservation consents and tracking key performance indicators in the lab.
Target Audience
The primary target audience includes embryologists, IVF clinic directors, and other fertility specialists seeking to improve embryo selection accuracy, streamline laboratory workflows, and increase pregnancy success rates.
Features
- AI-driven analysis of embryo imaging data from time-lapse microscopes
- Integration with patient-specific clinical characteristics for personalized assessment
- Automated embryo ranking based on predictive algorithms
- Compatibility with MIRI®, GERI®, EMBRYOSCOPE®, and EMBRYOSCOPE+® time-lapse microscope models
- Digital platform for managing cryopreservation consent renewals
- Real-time tracking of key performance indicators (KPIs) for IVF laboratories
- Secure digital platform for evaluating embryonic development
- CE and UKCA MARKING certification, complying with medical device standards